Back to top

zacks-rank: Archive

Zacks Equity Research

New to Investing? This 1 Finance Stock Could Be the Perfect Starting Point

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

Zacks Equity Research

Why Goldman Sachs (GS) is a Top Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.

Zacks Equity Research

Why This 1 Computer and Technology Stock Could Be a Great Addition to Your Portfolio

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.

Zacks Equity Research

Why Lam Research (LRCX) is a Top Stock for the Long-Term

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

Zacks Equity Research

This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.

Zacks Equity Research

Why Hecla Mining (HL) Might be Well Poised for a Surge

Hecla Mining (HL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks Equity Research

Surging Earnings Estimates Signal Upside for Core & Main (CNM) Stock

Core & Main (CNM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks Equity Research

Cullen/Frost (CFR) Upgraded to Buy: Here's What You Should Know

Cullen/Frost (CFR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

Vivos Therapeutics (VVOS) Upgraded to Buy: Here's What You Should Know

Vivos Therapeutics (VVOS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

Stitch Fix (SFIX) Upgraded to Buy: Here's Why

Stitch Fix (SFIX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).